- Raised $8M Series A led by Avigdor Orlinsky, Apr 2022
- Raised $8M Seed round, Jan 2016
- Raised $1.9M grant, Jun 2026
About
Salignostics is an Israeli company pioneering saliva-based rapid diagnostic tests, transforming saliva into a reliable body fluid for immunoassays. Leveraging cutting-edge technology, their platform enables non-invasive, accessible, and cost-effective testing for a range of conditions, including pregnancy (Salistick™), COVID-19 (SaliCov™), HIV, and high-risk pregnancy complications. Founded in 2016 by researchers from the Hebrew University of Jerusalem, Salignostics aims to revolutionize the diagnostics market by making testing faster, safer, and more scalable for home use, point-of-care, and laboratories. In 2024, Salignostics was recognized as one of Time magazine's 100 Most Influential in Healthcare and was the only saliva diagnostics company to reach the final stage of NIH's RADx Initiative for COVID-19. Salistick™ was also celebrated as a 2023 Time Magazine Best Invention.
Funding history · 4 rounds · $22.0M total
Q&A
- What is Salignostics' primary focus in the diagnostics market?
- Salignostics is an Israeli company focused on pioneering saliva-based rapid diagnostic tests, aiming to transform saliva into a reliable body fluid for immunoassays across various conditions.
- When was Salignostics founded and by whom?
- Salignostics was founded in 2016 by researchers from the Hebrew University of Jerusalem, including Aaron Palmon, Omer Deutsch, Guy Krief, Raluca Cohen, and Yoav Neumann.
- What was Salignostics' most recent funding round?
- Salignostics completed a Series A funding round in April 2022, raising $8,000,000. The round was led by Avigdor Orlinsky and included ARC Innovation Center and Yissum.
- What is the total amount of funding Salignostics has raised to date?
- Salignostics has raised a total of $22,000,000 across its funding rounds.
- How many employees does Salignostics currently have?
- Salignostics has 11-50 employees.
- Which of Salignostics' products received recognition in 2023 and 2024?
- Salignostics' Salistick™ was recognized as a 2023 Time Magazine Best Invention, and in 2024, Salignostics was named one of Time magazine's 100 Most Influential in Healthcare.
- What grant did Salignostics receive in 2026?
- In June 2026, Salignostics received a grant of $1,870,000 from the Bill & Melinda Gates Foundation.
- What are the key applications of Salignostics' saliva-based diagnostic platform?
- Salignostics' platform enables non-invasive, accessible, and cost-effective testing for conditions such as pregnancy (Salistick™), COVID-19 (SaliCov™), HIV, and high-risk pregnancy complications.
Team · 7
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | salignostics.com/ |
|---|---|
| linkedin.com/company/salignostics/ |
Identifiers & details
| Legal name | Salignostics Ltd. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | salignostics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|